Oral manifestations of connective tissue disease and novel therapeutic approaches

Kenisha R. Heath, Roy S. Rogers, Nasim Fazel

Research output: Contribution to journalReview article

Abstract

Connective tissue diseases such as systemic lupus erythematosus (SLE), systemic sclerosis (SSc), and Sjögren syndrome (SS) have presented many difficulties both in their diagnosis and treatment. Known causes for this difficulty include uncertainty of disease etiology, the multitude of clinical presentations, the unpredictable disease course, and the variable cell types, soluble mediators, and tissue factors that are believed to play a role in the pathogenesis of connective tissue diseases. The characteristic oral findings seen with these specific connective tissue diseases may assist with more swift diagnostic capability. Additionally, the recent use of biologics may redefine the success rate in the treatment and management of the disease. In this review we describe the oral manifestations associated with SLE, SSc, and SS and review the novel biologic drugs used to treat these conditions.

Original languageEnglish (US)
JournalDermatology Online Journal
Volume21
Issue number10
StatePublished - Oct 1 2015

Fingerprint

Oral Manifestations
Connective Tissue Diseases
Systemic Scleroderma
Systemic Lupus Erythematosus
Thromboplastin
Disease Management
Biological Products
Uncertainty
Therapeutics
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Dermatology

Cite this

Oral manifestations of connective tissue disease and novel therapeutic approaches. / Heath, Kenisha R.; Rogers, Roy S.; Fazel, Nasim.

In: Dermatology Online Journal, Vol. 21, No. 10, 01.10.2015.

Research output: Contribution to journalReview article

@article{2e55822ee3f345dbbd6af50498ecb3b3,
title = "Oral manifestations of connective tissue disease and novel therapeutic approaches",
abstract = "Connective tissue diseases such as systemic lupus erythematosus (SLE), systemic sclerosis (SSc), and Sj{\"o}gren syndrome (SS) have presented many difficulties both in their diagnosis and treatment. Known causes for this difficulty include uncertainty of disease etiology, the multitude of clinical presentations, the unpredictable disease course, and the variable cell types, soluble mediators, and tissue factors that are believed to play a role in the pathogenesis of connective tissue diseases. The characteristic oral findings seen with these specific connective tissue diseases may assist with more swift diagnostic capability. Additionally, the recent use of biologics may redefine the success rate in the treatment and management of the disease. In this review we describe the oral manifestations associated with SLE, SSc, and SS and review the novel biologic drugs used to treat these conditions.",
author = "Heath, {Kenisha R.} and Rogers, {Roy S.} and Nasim Fazel",
year = "2015",
month = "10",
day = "1",
language = "English (US)",
volume = "21",
journal = "Dermatology Online Journal",
issn = "1087-2108",
publisher = "Department of Dermatology UC Davis",
number = "10",

}

TY - JOUR

T1 - Oral manifestations of connective tissue disease and novel therapeutic approaches

AU - Heath, Kenisha R.

AU - Rogers, Roy S.

AU - Fazel, Nasim

PY - 2015/10/1

Y1 - 2015/10/1

N2 - Connective tissue diseases such as systemic lupus erythematosus (SLE), systemic sclerosis (SSc), and Sjögren syndrome (SS) have presented many difficulties both in their diagnosis and treatment. Known causes for this difficulty include uncertainty of disease etiology, the multitude of clinical presentations, the unpredictable disease course, and the variable cell types, soluble mediators, and tissue factors that are believed to play a role in the pathogenesis of connective tissue diseases. The characteristic oral findings seen with these specific connective tissue diseases may assist with more swift diagnostic capability. Additionally, the recent use of biologics may redefine the success rate in the treatment and management of the disease. In this review we describe the oral manifestations associated with SLE, SSc, and SS and review the novel biologic drugs used to treat these conditions.

AB - Connective tissue diseases such as systemic lupus erythematosus (SLE), systemic sclerosis (SSc), and Sjögren syndrome (SS) have presented many difficulties both in their diagnosis and treatment. Known causes for this difficulty include uncertainty of disease etiology, the multitude of clinical presentations, the unpredictable disease course, and the variable cell types, soluble mediators, and tissue factors that are believed to play a role in the pathogenesis of connective tissue diseases. The characteristic oral findings seen with these specific connective tissue diseases may assist with more swift diagnostic capability. Additionally, the recent use of biologics may redefine the success rate in the treatment and management of the disease. In this review we describe the oral manifestations associated with SLE, SSc, and SS and review the novel biologic drugs used to treat these conditions.

UR - http://www.scopus.com/inward/record.url?scp=84988028147&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84988028147&partnerID=8YFLogxK

M3 - Review article

C2 - 26632801

VL - 21

JO - Dermatology Online Journal

JF - Dermatology Online Journal

SN - 1087-2108

IS - 10

ER -